International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 2460-2465
Research Article
Demographic, Clinical, and Mycological Features of Tinea Capitis in Pediatric Patients: A Hospital-Based Study from Northern India
 ,
 ,
 ,
Received
March 6, 2026
Accepted
March 20, 2026
Published
April 11, 2026
Abstract

Background:  Tinea capitis is a common fungal infection of the scalp and hair in children, caused mainly by Trichophyton and Microsporum species, and manifests in different clinical forms. This study aims to characterize the demographic, clinical, and microbiological features of Tinea capitis among children in a district of Northern India.

Materials and Methods:  A total of 128 pediatric patients with clinically diagnosed Tinea capitis were included. Data on demographic details and mycological characteristics were collected. All participants underwent KOH microscopy and fungal culture, with the mycological profile analyzed accordingly.

Results:  Most children were between 6 and 10 years old (60.2%) and with a male predominance (66.4%). The most common complaints were itching (94.5%) and scaling (73.4%). The black dot form was the predominant clinical presentation (57%), with most children having 2–5 patches (74.2%). The KOH test was positive in 66.4% of cases. Fungal cultures yielded positive results in 68% of samples, with Trichophyton mentagrophytes (34.4%) and T. rubrum (11.7%) being the most frequently isolated species.

Conclusion:  This study emphasizes key clinical factors for early diagnosis and offers region-specific data, but its hospital-based nature limits generalizability, indicating a need for broader population research to better understand tinea capitis prevalence.

Keywords
INTRODUCTION

Dermatophytes are filamentous fungi that thrive on keratin, mainly infecting keratin-rich tissues like nails, hair, and the outer skin layers in humans and animals. [1-3] Tinea capitis is a common dermatophyte infection that primarily affects the scalp and hair shafts. It is often referred to as ringworm of the head and most frequently occurs in children aged between 3 and 14 years. Clinically, it presents with hair loss (alopecia) and scaling of the affected scalp area [4,5].

 

Studies have cultured organisms responsible for Tinea capitis from various fomites such as combs, caps, pillowcases, toys, and even theatre seats. Additionally, hairs shed by infected individuals can harbor infectious fungi for over a year. The presence of asymptomatic carriers further complicates efforts to eradicate Tinea capitis completely.[6]

 

The clinical presentation of Tinea capitis can vary depending on the severity of the infection. In its mild, subclinical stages, it often appears as small areas of erythema accompanied by patches of scaly skin, with hairs broken at the skin surface, commonly known as "black dots," and crusting. More advanced or severe cases tend to exhibit intense inflammatory responses, including folliculitis. As the infection progresses, it may lead to the formation of kerions, which are inflamed, boggy nodules that can result in scarring and expanding areas of hair loss. In some instances, systemic symptoms such as fever, malaise, and regional lymphadenopathy may be observed.[4,5]

 

The mycological spectrum of Tinea capitis is highly diverse, involving both Trichophyton and Microsporum genera.[5,7,8, 9] There is significant variation in the predominant fungal species across different geographical regions, climates, and time periods. Even within the same region, the dominant species and associated clinical and demographic features can differ notably.

 

In this study, we aim to describe the demographic, clinical, and microbiological characteristics of Tinea capitis among children in a district of Northern India.

 

MATERIALS and METHODS

This cross-sectional study was conducted at the Department of Dermatology, Venereology & Leprosy, in collaboration with the Department of Microbiology at Era’s Lucknow Medical College & Hospital, Lucknow.

 

The inclusion criteria encompassed children under 14 years of age with a clinical diagnosis of Tinea capitis, along with their legal guardians or parents. Children who were critically ill, those currently undergoing antifungal treatment, and individuals unwilling to participate were excluded from the study.

 

The sample size was estimated based on a previous study by Grover et al.[10]. Using the formula for sample size calculation, with a prevalence (p) of 41.5% and a Type I error (α) set at 10%, the initial calculation yielded a requirement of 80 participants. To account for an anticipated 30% loss to follow-up, the total sample size was adjusted to 104.

 

Sample Size Estimation: The projections for sample size were based on a study by Grover et al.[10] Sample size was calculated using the following formula:-

 

During the study period from January 2014 to June 2015, a total of 128 patients presenting to the outpatient department were enrolled, exceeding the minimum required sample size.

 

The study protocol received approval from the Institutional Ethics Committee (Letter No. ELMC/EC/R. Cell/2013; dated 22 Nov 2013). Prior to enrollment, detailed information about the study’s purpose and procedures was explained to the parents, and informed consent was obtained. For children above 12 years of age, assent was also secured.

 

At the time of enrollment, demographic data were documented. For children exhibiting symptoms, details regarding the duration and nature of their complaints were recorded. A comprehensive clinical examination was performed on each child. The dermatological assessment involved a detailed skin examination, with clinical typing aided by Wood’s lamp examination to evaluate lesion color, pattern, inflammation, and distribution.

 

Sample collection involved preparing a 20% potassium hydroxide (KOH) wet mount for direct microscopy. A small portion of skin scrapings was placed on a clean glass slide, treated with a drop of 10% KOH and dimethyl sulfoxide, covered with a cover slip, and gently heated to flatten the sample. After 15–20 minutes, the slide was examined under low power (10X or 40X) microscopy to identify hyphae and spores.

 

Fungal culture was performed by inoculating samples onto Sabouraud Dextrose Agar (SDA) plates containing chloramphenicol (0.5 mg/ml) and cycloheximide (0.5 mg/ml). Inoculation was carried out with a sterile L-shaped loop in the center of each plate. The cultures were incubated at 25°C in a BOD incubator and at room temperature (37°C). Plates were examined daily for growth and were discarded if no growth was observed after four weeks. Fungal isolates from positive cultures were further examined using lactophenol cotton blue (LCB) mounts under light microscopy. Species identification was refined through slide culture techniques to determine the precise genus and species of fungi.

 

Data collected was analyzed using the Statistical Package for Social Sciences (SPSS) version 21.0. The study was purely descriptive, and data were presented as numbers and percentages.

 

RESULTS

A total of 1595 children falling in the sampling frame underwent clinical evaluation. Out of these 128 (8%) were found to be clinically positive for T. Capitis. The majority of cases were males (n=85; 66.4%), while there were 43 (33.6%) females. The male-to-female ratio among study subjects was approximately 1.98:1.

 

Regarding age distribution, the highest number of cases occurred in the 6–10 years age group (n=77; 60.2%), followed by those aged >10 years (n=41; 32.0%) and 0–5 years (n=10; 7.8%).

 

Gender Distribution of patients

 

Figure 2: Age distribution of patients

 

Clinically, the most common type was the black dot type, observed in 57% of cases, followed by grey patch (38.3%) and inflammatory type (4.7%). Solitary lesions were present in only 14 (10.9%) cases. The majority of patients (74.2%) had 2-5 patches, while 19 (14.8%) had more than 5 patches. The predominant presenting complaints were itching (94.5%) and scaling (73.4%). Additionally, 52 (40.6%) cases reported hair loss, and 6 (5.7%) had lesions with discharge and erythema.

 

Table 2: Clinical Profiles of Patients

SN

Characteristic

Number of patients

Percentage

1.

Clinical Type

 

 

Black dot type

73

57.0

Grey patch

49

38.3

Inflammatory type

6

4.7

2.

No. of patches

 

 

Only 1 patch

14

10.9

2-5 patches

95

74.2

More than 5 patches

19

14.8

3.

Clinical Complaints

 

 

Itching

121

94.5

Scaling

94

73.4

Hair loss

52

40.6

Lesions with discharge and erythema

6

4.7

 

On culture, 87 (68%) specimens were positive. The most common mycological pathogen was T. mentagrophytes (n=44; 34.4%), followed by T. rubrum (n=15; 11.7%), T. verrucosum (n=11; 8.6%), M. audouinii (n=8; 6.3%), and M. canis (n=4; 3.1%) (Figure 1).

     

Figure 1: Cultural positivity and pattern among patients

 

A total of 85 (66.4%) specimens were KOH-positive for fungal strains. When evaluating the efficacy of KOH positivity against culture positivity, it was found to have a sensitivity of 72.4% and a specificity of 46.3%. The positive and negative predictive values of direct microscopy were 74.1% and 44.2%, respectively. The overall accuracy of KOH microscopy was 63.3% (Table 3).

 

Table 3: Association between KOH positivity and culture positivity

SN

KOH Positivity

 

Culture Positivity

Total

Positive

Negative

1.

Positive

63

22

85

2.

Negative

24

19

43

Sensitivity: 72.4%; Specificity: 46.3%; PPV: 74.1%; NPV: 44.2%; Accuracy: 63.3%

 

Table 4: Association of fungal element positivity with clinical presentation and duration of symptoms

SN

Parameter

Positive (n=87)

Negative (n=41)

Statistical significance

No.

%

No.

%

c2

‘p’

1.

Duration

 

 

 

 

 

 

Asymptomatic

24

27.6

10

24.4

0.871

0.832

<3 months

39

44.8

21

51.2

4-6 months

23

26.4

9

22.0

>6 months

1

1.1

1

2.4

2.

Tonsuring

49

56.3

25

61.0

0.247

0.619

3.

Clinical type

 

 

 

 

 

 

Black dot type

47

54.0

26

63.4

2.601

0.272

Grey patch

37

42.5

12

29.3

Inflammatory type

3

3.4

3

7.3

4.

No. of patches

 

 

 

 

 

 

Only 1 patch

9

10.3

5

12.2

10.541

0.005

2-5 patches

59

67.8

36

87.8

>5 patches

19

21.8

0

0.0

5.

Complaints

 

 

 

 

 

 

Itching

79

90.8

35

84.6

0.846

0.358

Scaling

70

80.5

24

58.5

6.866

0.009

Hair loss

44

50.6

10

24.4

7.834

0.005

Lesions with discharge and erythema

5

5.7

1

2.4

0.683

0.409

 

No significant association between fungal element positivity and duration, tonsuring and clinical type could be seen. However, increasing number of patches and complaints like scaling and hair loss were seen to be significantly associated with fungal element positivity (p<0.05).

 

DISCUSSION

The current study found that the majority of patients were children aged 6-10 years (60.2%), and were males (66.4%). Tinea capitis is most frequently observed in children aged 3 to 14 years, accounting for up to 92.5% of dermatophyte infections in children under 10 [6]. Recent research by Kassem et al. revealed a predominance of children aged 4-6 years (81.6%) and males (72.4%) within an immigrant refugee population [11]. Similarly, Mohta et al. reported that male children aged 6-10 years (72.6%) were most affected [12]. A meta-analysis of 14 studies involving 9,465 schoolchildren also confirmed increased susceptibility among boys under 10 years [13]. Age-specific and site-specific variation in fungal species was observed, and some gender-related differences in pathogen distribution were also noted in a Poland study [14]. These findings align with the age and sex distribution observed in our study. Tinea capitis most frequently affects prepubertal children [15].

 

Clinically, itching, scaling, and hair loss were the most common presenting complaints, consistent with other studies [16,17]. Mohta et al. noted that itching and inflammation significantly impact children’s quality of life, which may explain why symptomatic children in our study sought medical attention [12]. Interestingly, some asymptomatic children were diagnosed, emphasizing that even short-duration symptoms—averaging 2.33 months—can lead to noticeable clinical signs.

 

The most common clinical types identified were black dot and grey patch, with many children exhibiting multiple lesions. These findings are in line with other research indicating these as predominant clinical forms [12,18-20]. The grey patch type was also the most frequent presentation, (65% of cases) in a Telangana study by Pavani et al [21]. KOH examination identified fungal elements in all samples, while fungal cultures were positive in 40% of cases, with T. violaceum being the most common pathogen isolated in the Telangana study.

 

Diagnostic tests showed similar positivity rates: 66.4% for KOH preparation and 68% for fungal culture. Compared to Mohta et al., who reported lower rates (32.9% and 40.8%), our higher detection rates may reflect differences in techniques or patient populations [12]. While KOH examination is sensitive, it lacks specificity, making culture essential for definitive identification. Our study found direct microscopy was 63.3% accurate relative to culture, indicating that both methods are complementary [22].

 

Fungal culture predominantly yielded Trichophyton species (90.8%), with Microsporum species making up the remaining 9.2%. This pattern aligns with most previous studies [11,23,24]. However, Zeng et al. reported Microsporum dominance, indicating regional variations [20]. The main species identified were T. mentagrophytes and T. rubrum among Trichophyton, and M. audouinii and M. canis among Microsporum.

 

Reviewing regional literature from northern India, especially Lucknow, reveals variability in fungal profiles. Shukla et al. identified T. tonsurans, T. mentagrophytes, M. ferrugineum, T. verrucosum, and M. audouinii as common isolates in our setting [25]. Sahai and Mishra reported similar findings [18]. Conversely, Grover et al. and Ahmed et al. found T. violaceum to be prevalent, whereas our study did not identify this species [10, 17]. Such differences underscore the dynamic nature of fungal epidemiology, influenced by globalization and increased contact with carriers from diverse regions, which necessitate ongoing surveillance.

 

Strengths of this study include its focus on relevant clinical factors, which can aid in early diagnosis and management. Additionally, it provides valuable data specific to the local population, contributing to regional understanding of the condition. A limitation of this hospital-based study is that the findings may not reflect the broader community, and additional research is necessary to verify prevalence, as results may differ beyond our specific population in Lucknow.

 

CONCLUSION

The present study showed that paediatric Tinea capitis in Lucknow city was characterized by younger age (≤10 years) and male gender. Itching and scaling, multiple patches and black dot type were common clinical features. Culture positivity rate was 68% with dominance of T. mentagrophytes and T. rubrum as the mycological pathogens.

 

REFERENCES

  1. Weitzman I, Summerbell RC. The dermatophytes.  Microbiol. Rev. 1995;8 (2):240-259.
  2. Drakensjö IT, Chryssanthou E. Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005–2009.  Mycol.2011; 49(5): 484–488.
  3. AL-Khikani FH. Dermatophytosis a worldwide contiguous fungal infection: Growing challenge and few solutions. Biomed Biotechnol Res. J. 2020 ; 4:117-22.
  4. Hainer BL. Dermatophyte Infections. Fam. Physician. 2003; 67:101-8.
  5. Ely JW, Rosenfeld S, Stone MS. Diagnosis and Management of Tinea Am. Fam. Physician. 2014;90(10):702-710.
  6. Pomeranz AJ and Sabins SS. Tinea capitis: epidemiology, diagnosis and management strategies. Drugs 2009; 4(12):779-83.
  7. Weitzman I, Summerbell RC. The dermatophytes.  Microbiol. Rev. 1995;8(2):240-259.
  8. Aly R. Ecology, epidemiology and diagnosis of Tinea capitis. Inf. Dis .J. 1999; 18:180-5.
  9. Abdel-Rahman SM, Nahata MC. Treatment of Tinea capitis. Pharmacother. 1997;31:338-48.
  10. [1] Grover CArora PManchanda V. Tinea capitis in the paediatric population: a study from North India. Indian. J . Dermatol .Venereol. Leprol.2010; 76(5):527-32.
  11. Kassem R, Shemesh Y, Nitzan O, Azrad M, Peretz A. Tinea capitis in an immigrant paediatric community; a clinical signs-based treatment approach. BMC Paediatr. 2021;21(1):363.
  12. Mohta A, Singh A, Nyati A, Agrawal A, Nahar D, Lal M, et al. Evaluation of Impact of Tinea capitis on Quality of Life in Paediatric Patients Using Children's Dermatology Life Quality Index and Its Correlation with Disease Duration. J. Trichol. 2020;12(5):213-219.
  13. Birhanu MY, Temesgen H, Ketema DB, Desta M, Getaneh T, Bekele GM, Zeleke B, Jemberie SS. Tinea capitis among schoolchildren in Ethiopia: A systematic review and meta analysis. PLoS One. 2023;18(2):e0280948. 
  14. Rychlik K, Sternicka J, Zabłotna M, Nowicki RJ, Bieniaszewski L, Purzycka-Bohdan D. Superficial Fungal Infections in the Pediatric Dermatological Population of Northern Poland. Journal of Fungi. 2025; 11(7):533. https://doi.org/10.3390/jof11070533
  15. Kovitwanichkanont, T.; Chong, A.H. Superficial fungal infections. Aust. J. Gen. Pract. 2019, 48, 706–711.
  16. [1] Kundu DMandal LSen G. Prevalence of Tinea capitis in school going children in Kolkata, West Bengal. J. Nat. Sci. Biol. Med.2012 Jul;3(2):152-5.
  17. Ahmed I, Ahmed Z, Nasreen S. Prevalence of tinea capitis and asymptomatic carriage amongst school going children. Pakistan Asso. Dermatologists 2006; 16: 215-219.
  18. Sahai S, Mishra D. Emergence of Trichophyton tonsurans in Tinea capitis cases in Lucknow: A hospital based study. Indian J. Basic Med. Res. 2013; 6(2): 619-
  19. Mane V, Urhekar AD, Mali S, Patil N, Patil SA, Ajit KG. Trichophyton violaceum- a major cause of Tinea capitis in tertiary care hospitals and its antifungal susceptibility testing. IJBPAS 2013; 2(4): 915-928.
  20. Zeng J, Wang S, Guo L, Lv S, Shan B, Liu Z, Li F. Paediatric Tinea capitis in Jilin Province: analyzing previous results from a new perspective. 2023; 188: 515–522.
  21. Pavani K, Padma A, Jarang T, Kavitha SB. A study on the clinico-epidemiological and mycological correlations of tinea capitis in a tertiary care hospital in Telangana. Int J Acad Med Pharm. 2024;6(2):845-852.
  22. Levitt JO, Levitt BH, Akhavan A, Yanofsky H. The sensitivity and specificity of potassium hydroxide smear and fungal culture relative to clinical assessment in the evaluation of Tinea pedis: a pooled analysis. Res. Pract. 2010;2010:764843.
  23. Kechia FA, Kouoto EA, Nkoa T, Nweze EI, Fokoua DC, Fosso S, Somo MR. Epidemiology of Tinea capitis among school-age children in Meiganga, Cameroon. Mycol. Med. 2014;24(2):129-34.
  24. Bongomin F, Olum R, Nsenga L, Namusobya M, Russell L, de Sousa E, et al. Estimation of the burden of Tinea capitis among children in Africa. 2021;64(4):349-363.
  25. Shukla P, Yaqoob S, Shukla V, Garg J, Dar ZP, Haider F. Prevalence of superficial mycoses among outdoor patients in a tertiary care hospital. Nat. J. Med.  All. Sci. 2013; 2(2): 19-26.
Recommended Articles
Research Article Open Access
Antibiotics Utilization in Otorhinolaryngology Department: An Insight from a Cross-sectional Study in a Tertiary Care Hospital
2026, Volume-7, Issue 2 : 2442-2447
Research Article Open Access
Complex Enteric Fistulae: A Case Series from a Tertiary Care Centre
2026, Volume-7, Issue 2 : 2438-2441
Research Article Open Access
From Guidelines to the Bedside: A Cross-Sectional Analysis of Infection Control Knowledge, Attitude and Practice among Healthcare Workers in Indian Hospitals
2026, Volume-7, Issue 2 : 2448-2459
Case Report Open Access
Infantile Neuroregression as a Presentation of Sandhoff Disease: A Case Study
2026, Volume-7, Issue 2 : 2503-2505
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
6 Views
9 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved